Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma

• Billy Amzal ,

  Roles Conceptualization, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: b.amzal@analytica-laser.com

  Affiliation Decision Analytics and Value in Access, Analytica LA-SER, London, England

  ⨯
• Shuai Fu,

  Roles Conceptualization, Formal analysis, Software, Validation, Writing – original draft, Writing – review & editing

  Affiliation Decision Analytics and Value in Access, Analytica LA-SER, London, England

  ⨯
• Jie Meng,

  Roles Conceptualization, Data curation, Resources, Software, Validation, Writing – original draft, Writing – review & editing

  Affiliation Decision Analytics and Value in Access, Analytica LA-SER, London, England

  ⨯
• Johanna Lister,

  Roles Conceptualization, Data curation, Resources, Validation, Writing – original draft, Writing – review & editing

  Affiliation Decision Analytics and Value in Access, Analytica LA-SER, London, England

  http://orcid.org/0000-0002-7166-4758

  ⨯
• Helene Karcher

  Roles Conceptualization, Methodology, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Decision Analytics and Value in Access, Analytica LA-SER, London, England

  ⨯